Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC)

Published:2020-05 Issue: Volume:125 Page:109561
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Song Yinxue,Zhou Bin,Du Xiangyang,Wang Yong,Zhang Jie,Ai Yanqiu,Xia Zongjiang,Zhao Gaofeng

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference54 articles.

1. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial;Pless;Lancet,2015

2. A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer;Kasinski;Oncogene,2015

3. Induction of reactive oxygen species-stimulated distinctive autophagy by chelerythrine in non-small cell lung cancer cells;Tang;Redox Biol.,2017

4. Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients;Xu;Lung Cancer,2012

5. Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy;Chen;Radiother. Oncol.,2013

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in non-viral nanoparticle-based gene therapy for effective management of cancer;Journal of Drug Delivery Science and Technology;2024-10

2. Non-viral vectors combined delivery of siRNA and anti-cancer drugs to reverse tumor multidrug resistance;Biomedicine & Pharmacotherapy;2024-09

3. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress;Molecular Therapy - Nucleic Acids;2024-09

4. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

5. Mesoporous silica nanoparticles: a versatile carrier platform in lung cancer management;Nanomedicine;2024-05-20